Biotechnology - San Francisco, California, United States
Delinia is a biotechnology company developing novel therapeutics for the treatment of serious autoimmune diseases.Delinia's lead program is a molecule that potentiates and expands Regulatory T Cells (Tregs), powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the pathophysiology of cancer and autoimmune disease.